| Mary Mayzel, CNM | |
|
2003 Medical Pkwy, Suite G50, Annapolis, MD 21401-7992 | |
| (443) 573-1094 | |
| (443) 573-1097 |
| Full Name | Mary Mayzel |
|---|---|
| Gender | Female |
| Speciality | Advanced Practice Midwife |
| Location | 2003 Medical Pkwy, Annapolis, Maryland |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1356750996 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367A00000X | Advanced Practice Midwife | R189238 (Maryland) | Primary |
| Entity Name | University Of Maryland St Joseph Medical Group Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1770836785 PECOS PAC ID: 4880846179 Enrollment ID: O20121213000234 |
News Archive
A new test that can predict whether a patient's cancer will spread beyond the breast site has been developed by scientists at the UCD Conway Institute, University College Dublin and St Vincent's University Hospital, Dublin, Ireland.
Children with attention deficit hyperactivity disorder (ADHD) should get careful cardiac evaluation and monitoring - including an electrocardiogram (ECG) - before treatment with stimulant drugs, a new American Heart Association statement recommends.
Research funded by the National Institutes of Health suggests that changes in a small region of chromosome 6 are risk factors for peanut allergy in U.S. children of European descent. The genetic risk area is located among two tightly linked genes that regulate the presentation of allergens and microbial products to the immune system. This study is the first to use a genome-wide screening approach in patients with well-defined food allergy to identify risks for peanut allergy.
A potent cancer-fighting molecule in our cells can be reawakened by reducing levels of a protein - called SET - that's often found in excess in cancer cells, a new study from Columbia University's Herbert Irving Comprehensive Cancer Center has found.
Barr Pharmaceuticals, Inc. has confirmed that its subsidiary, Barr Laboratories, Inc., has initiated a challenge of the patents listed by Sepracor Inc. in connection with its Xopenex (Levalbuterol Hydrochloride) 0.31mg/3mL, 0.63mg/3mL and 1.25mg/3mL.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mary Mayzel, CNM 1455 Andre St, Baltimore, MD 21230-5305 Ph: (703) 447-5841 | Mary Mayzel, CNM 2003 Medical Pkwy, Suite G50, Annapolis, MD 21401-7992 Ph: (443) 573-1094 |
News Archive
A new test that can predict whether a patient's cancer will spread beyond the breast site has been developed by scientists at the UCD Conway Institute, University College Dublin and St Vincent's University Hospital, Dublin, Ireland.
Children with attention deficit hyperactivity disorder (ADHD) should get careful cardiac evaluation and monitoring - including an electrocardiogram (ECG) - before treatment with stimulant drugs, a new American Heart Association statement recommends.
Research funded by the National Institutes of Health suggests that changes in a small region of chromosome 6 are risk factors for peanut allergy in U.S. children of European descent. The genetic risk area is located among two tightly linked genes that regulate the presentation of allergens and microbial products to the immune system. This study is the first to use a genome-wide screening approach in patients with well-defined food allergy to identify risks for peanut allergy.
A potent cancer-fighting molecule in our cells can be reawakened by reducing levels of a protein - called SET - that's often found in excess in cancer cells, a new study from Columbia University's Herbert Irving Comprehensive Cancer Center has found.
Barr Pharmaceuticals, Inc. has confirmed that its subsidiary, Barr Laboratories, Inc., has initiated a challenge of the patents listed by Sepracor Inc. in connection with its Xopenex (Levalbuterol Hydrochloride) 0.31mg/3mL, 0.63mg/3mL and 1.25mg/3mL.
› Verified 2 days ago
Cristin Autrey Gilley, CNM Advanced Practice Midwife Medicare: Not Enrolled in Medicare Practice Location: 2003 Medical Pkwy, Suite G50, Annapolis, MD 21401 Phone: 410-573-1094 Fax: 410-573-1097 | |
Vicki E. Long, C.N.M. Advanced Practice Midwife Medicare: Not Enrolled in Medicare Practice Location: 2000 Medical Pkwy, Ste 304, Annapolis, MD 21401 Phone: 410-573-9530 Fax: 410-573-9569 | |
Kimla Raye Mcdonald, Advanced Practice Midwife Medicare: Not Enrolled in Medicare Practice Location: 2003 Medical Pkwy, Suite G50, Annapolis, MD 21401 Phone: 410-573-1094 Fax: 410-573-1097 | |
Jennifer Ann Caniglio, CNM Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: 2003 Medical Pkwy, Suite G50, Annapolis, MD 21401 Phone: 410-573-1094 Fax: 410-573-1097 | |
Shaina Morgan French, RN, CNM Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: 2003 Medical Pkwy, Suite G50, Annapolis, MD 21401 Phone: 410-573-1094 | |
Miss Melanie Ridgway Furrer, CNM, MSPHN, RN Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: 2003 Medical Pkwy Ste G50, Annapolis, MD 21401 Phone: 443-481-4400 Fax: 410-573-1097 |